Metformin decreases hyaluronan synthesis by vascular smooth muscle cells

Metformin is the first-line drug in the treatment of type 2 diabetes worldwide based on its effectiveness and cardiovascular safety. Currently metformin is increasingly used during pregnancy in women with gestational diabetes mellitus, even if the long-term effects of metformin on offspring are not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Investig Med
Autors principals: Sainio, Annele, Takabe, Piia, Oikari, Sanna, Salomäki-Myftari, Henriikka, Koulu, Markku, Söderström, Mirva, Pasonen-Seppänen, Sanna, Järveläinen, Hannu
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7063400/
https://ncbi.nlm.nih.gov/pubmed/31672719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jim-2019-001156
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars